{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T02:22:38Z","timestamp":1781749358373,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Scientific Foundation of China","award":["81560283"],"award-info":[{"award-number":["81560283"]}]},{"name":"Natural Scientific Foundation of China","award":["81201084"],"award-info":[{"award-number":["81201084"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2020A1515011332"],"award-info":[{"award-number":["2020A1515011332"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515012503"],"award-info":[{"award-number":["2022A1515012503"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific and technological projects of Nanshan","award":["NS2022007"],"award-info":[{"award-number":["NS2022007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To develop and validate radiomics models for prediction of tumor response to neoadjuvant therapy (NAT) in patients with locally advanced rectal cancer (LARC) using both pre-NAT and post-NAT multiparameter magnetic resonance imaging (mpMRI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this multicenter study, a total of 563 patients were included from two independent centers. 453 patients from center 1 were split into training and testing cohorts, the remaining 110 from center 2 served as an external validation cohort. Pre-NAT and post-NAT mpMRI was collected for feature extraction. The radiomics models were constructed using machine learning from a training cohort. The accuracy of the models was verified in a testing cohort and an independent external validation cohort. Model performance was evaluated using area under the curve (AUC), sensitivity, specificity, positive predictive value, and negative predictive value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The model constructed with pre-NAT mpMRI had favorable accuracy for prediction of non-response to NAT in the training cohort (AUC\u2009=\u20090.84), testing cohort (AUC\u2009=\u20090.81), and external validation cohort (AUC\u2009=\u20090.79). The model constructed with both pre-NAT and post-NAT mpMRI had powerful diagnostic value for pathologic complete response in the training cohort (AUC\u2009=\u20090.86), testing cohort (AUC\u2009=\u20090.87), and external validation cohort (AUC\u2009=\u20090.87).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Models constructed with multiphase and multiparameter MRI were able to predict tumor response to NAT with high accuracy and robustness, which may assist in individualized management of LARC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-023-02368-4","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T10:02:22Z","timestamp":1698746542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Multiphase and multiparameter MRI-based radiomics for prediction of tumor response to neoadjuvant therapy in locally advanced rectal cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"Hongyan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixue","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1298-8506","authenticated-orcid":false,"given":"Yingwei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"2368_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"2368_CR2","doi-asserted-by":"publisher","first-page":"7253","DOI":"10.1158\/1078-0432.CCR-17-1038","volume":"23","author":"Z Liu","year":"2017","unstructured":"Liu Z, Zhang XY, Shi YJ, Wang L, Zhu HT, Tang Z, et al. Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Clin Cancer Res. 2017;23:7253\u201362.","journal-title":"Clin Cancer Res"},{"key":"2368_CR3","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.6004\/jnccn.2022.0051","volume":"20","author":"AB Benson","year":"2022","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Azad N, Chen YJ, Ciombor KK, et al. Rectal cancer, version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20:1139\u201367.","journal-title":"J Natl Compr Canc Netw"},{"key":"2368_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41575-019-0247-2","volume":"17","author":"AM Buckley","year":"2020","unstructured":"Buckley AM, Lynam-Lennon N, O\u2019Neill H, O\u2019Sullivan J. Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers. Nat Rev Gastroenterol Hepatol. 2020;17:298\u2013313.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2368_CR5","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.6004\/jnccn.2022.7061","volume":"20","author":"A Saraf","year":"2022","unstructured":"Saraf A, Roberts HJ, Wo JY, Parikh AR. Optimal neoadjuvant strategies for locally advanced rectal cancer by risk assessment and tumor location. J Natl Compr Canc Netw. 2022;20:1177\u201384.","journal-title":"J Natl Compr Canc Netw"},{"key":"2368_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10151-021-02564-y","volume":"26","author":"J Yang","year":"2022","unstructured":"Yang J, Wang W, Luo Y, Huang S, Fu Z. Effect of pathological complete response after neoadjuvant chemoradiotherapy on postoperative complications of rectal cancer: a systematic review and meta-analysis. Tech Coloproctol. 2022;26:163\u201374.","journal-title":"Tech Coloproctol"},{"key":"2368_CR7","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1200\/JCO.22.00032","volume":"40","author":"J Garcia-Aguilar","year":"2022","unstructured":"Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM, et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol. 2022;40:2546\u201356.","journal-title":"J Clin Oncol"},{"key":"2368_CR8","doi-asserted-by":"publisher","first-page":"e230146","DOI":"10.1001\/jamasurg.2023.0146","volume":"158","author":"PA Custers","year":"2023","unstructured":"Custers PA, van der Sande ME, Grotenhuis BA, Peters FP, van Kuijk SMJ, Beets GL, et al. Long-term quality of life and functional outcome of patients with rectal cancer following a watch-and-wait approach. JAMA Surg. 2023;158:e230146.","journal-title":"JAMA Surg"},{"key":"2368_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15:81\u201394.","journal-title":"Nat Rev Clin Oncol"},{"key":"2368_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/cells12030413","volume":"12","author":"JV Machado Carvalho","year":"2023","unstructured":"Machado Carvalho JV, Dutoit V, Corr\u00f2 C, Koessler T. Promises and challenges of predictive blood biomarkers for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Cells. 2023;12:413.","journal-title":"Cells"},{"key":"2368_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40364-021-00313-9","volume":"9","author":"A Alkan","year":"2021","unstructured":"Alkan A, Hofving T, Angenete E, Yrlid U. Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patients. Biomark Res. 2021;9:60.","journal-title":"Biomark Res"},{"key":"2368_CR12","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00330-017-5026-2","volume":"28","author":"RGH Beets-Tan","year":"2018","unstructured":"Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Curvo-Semedo L, et al. Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol. 2018;28:1465\u201375.","journal-title":"Eur Radiol"},{"key":"2368_CR13","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s00330-022-09086-7","volume":"33","author":"F Iafrate","year":"2023","unstructured":"Iafrate F, Ciccarelli F, Masci GM, Grasso D, Marruzzo F, De Felice F, et al. Predictive role of diffusion-weighted MRI in the assessment of response to total neoadjuvant therapy in locally advanced rectal cancer. Eur Radiol. 2023;33:854\u201362.","journal-title":"Eur Radiol"},{"key":"2368_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1148\/radiol.2020200287","volume":"297","author":"KM Bakke","year":"2020","unstructured":"Bakke KM, Meltzer S, Gr\u00f8vik E, Neg\u00e5rd A, Holmedal SH, Gjesdal KI, et al. Sex differences and tumor blood flow from dynamic susceptibility contrast MRI are associated with treatment response after chemoradiation and long-term survival in rectal cancer. Radiology. 2020;297:352\u201360.","journal-title":"Radiology"},{"key":"2368_CR15","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.3390\/cancers12071894","volume":"12","author":"B Petresc","year":"2020","unstructured":"Petresc B, Lebovici A, Caraiani C, Feier DS, Graur F, Buruian MM. Pre-treatment T2-WI based radiomics features for prediction of locally advanced rectal cancer non-response to neoadjuvant chemoradiotherapy: a preliminary study. Cancers (Basel). 2020;12:1894.","journal-title":"Cancers (Basel)"},{"key":"2368_CR16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/DCR.0000000000000743","volume":"60","author":"JJ van den Broek","year":"2017","unstructured":"van den Broek JJ, van der Wolf FS, Lahaye MJ, Heijnen LA, Meischl C, Heitbrink MA, et al. Accuracy of MRI in restaging locally advanced rectal cancer after preoperative chemoradiation. Dis Colon Rectum. 2017;60:274\u201383.","journal-title":"Dis Colon Rectum"},{"key":"2368_CR17","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1007\/s00330-021-08242-9","volume":"32","author":"Z Shu","year":"2022","unstructured":"Shu Z, Mao D, Song Q, Xu Y, Pang P, Zhang Y. Multiparameter MRI-based radiomics for preoperative prediction of extramural venous invasion in rectal cancer. Eur Radiol. 2022;32:1002\u201313.","journal-title":"Eur Radiol"},{"key":"2368_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00330-022-08952-8","volume":"33","author":"M Hou","year":"2023","unstructured":"Hou M, Zhou L, Sun J. Deep-learning-based 3D super-resolution MRI radiomics model: superior predictive performance in preoperative T-staging of rectal cancer. Eur Radiol. 2023;33:1\u201310.","journal-title":"Eur Radiol"},{"key":"2368_CR19","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/S2589-7500(21)00215-6","volume":"4","author":"L Feng","year":"2022","unstructured":"Feng L, Liu Z, Li C, Li Z, Lou X, Shao L, et al. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study. Lancet Digit Health. 2022;4:e8\u201317.","journal-title":"Lancet Digit Health"},{"key":"2368_CR20","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1038\/s41467-020-18162-9","volume":"11","author":"Z Liu","year":"2020","unstructured":"Liu Z, Meng X, Zhang H, Li Z, Liu J, Sun K, et al. Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer. Nat Commun. 2020;11:4308.","journal-title":"Nat Commun"},{"key":"2368_CR21","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14:749\u201362.","journal-title":"Nat Rev Clin Oncol"},{"key":"2368_CR22","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1001\/jamaoncol.2016.2631","volume":"2","author":"HJ Aerts","year":"2016","unstructured":"Aerts HJ. The potential of radiomic-based phenotyping in precision medicine: a review. JAMA Oncol. 2016;2:1636\u201342.","journal-title":"JAMA Oncol"},{"key":"2368_CR23","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1245\/s10434-019-07300-3","volume":"26","author":"X Zhou","year":"2019","unstructured":"Zhou X, Yi Y, Liu Z, Cao W, Lai B, Sun K, et al. Radiomics-based pretherapeutic prediction of non-response to neoadjuvant therapy in locally advanced rectal cancer. Ann Surg Oncol. 2019;26:1676\u201384.","journal-title":"Ann Surg Oncol"},{"key":"2368_CR24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1148\/radiol.211986","volume":"303","author":"J Shin","year":"2022","unstructured":"Shin J, Seo N, Baek SE, Son NH, Lim JS, Kim NK, et al. MRI radiomics model predicts pathologic complete response of rectal cancer following chemoradiotherapy. Radiology. 2022;303:351\u20138.","journal-title":"Radiology"},{"key":"2368_CR25","first-page":"2680","volume":"73","author":"AM Mandard","year":"1994","unstructured":"Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathol Correl Cancer. 1994;73:2680\u20136.","journal-title":"Clinicopathol Correl Cancer"},{"key":"2368_CR26","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3348\/kjr.2019.0797","volume":"21","author":"H Yoen","year":"2020","unstructured":"Yoen H, Park HE, Kim SH, Yoon JH, Hur BY, Bae JS, et al. Prognostic value of tumor regression grade on MR in rectal cancer: a large-scale, single-center experience. Korean J Radiol. 2020;21:1065\u201376.","journal-title":"Korean J Radiol"},{"key":"2368_CR27","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1097\/DCR.0000000000000667","volume":"59","author":"J Bhoday","year":"2016","unstructured":"Bhoday J, Smith F, Siddiqui MR, Balyasnikova S, Swift RI, Perez R, et al. Magnetic resonance tumor regression grade and residual mucosal abnormality as predictors for pathological complete response in rectal cancer postneoadjuvant chemoradiotherapy. Dis Colon Rectum. 2016;59:925\u201333.","journal-title":"Dis Colon Rectum"},{"key":"2368_CR28","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1469-185X.2010.00141.x","volume":"85","author":"S Nakagawa","year":"2010","unstructured":"Nakagawa S, Schielzeth H. Repeatability for Gaussian and non-Gaussian data: a practical guide for biologists. Biol Rev Camb Philos Soc. 2010;85:935\u201356.","journal-title":"Biol Rev Camb Philos Soc"},{"key":"2368_CR29","unstructured":"Elkan C. The foundations of cost-sensitive learning. In International Joint Conference on Artificial Intelligence 2001."},{"issue":"3","key":"2368_CR30","doi-asserted-by":"publisher","first-page":"e001717","DOI":"10.1136\/jitc-2020-001717","volume":"9","author":"A Wilkins","year":"2021","unstructured":"Wilkins A, Fontana E, Nyamundanda G, Ragulan C, Patil Y, Mansfield D, et al. Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer. J Immunother Cancer. 2021;9(3):e001717.","journal-title":"J Immunother Cancer"},{"key":"2368_CR31","doi-asserted-by":"publisher","first-page":"e2252140","DOI":"10.1001\/jamanetworkopen.2022.52140","volume":"6","author":"T Akiyoshi","year":"2023","unstructured":"Akiyoshi T, Wang Z, Kaneyasu T, Gotoh O, Tanaka N, Amino S, et al. Transcriptomic analyses of pretreatment tumor biopsy samples, response to neoadjuvant chemoradiotherapy, and survival in patients with advanced rectal Cancer. JAMA Netw Open. 2023;6:e2252140.","journal-title":"JAMA Netw Open"},{"key":"2368_CR32","doi-asserted-by":"publisher","first-page":"101964","DOI":"10.1016\/j.ctrv.2020.101964","volume":"84","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Glynne-Jones R. How to measure tumour response in rectal cancer? An explanation of discrepancies and suggestions for improvement. Cancer Treat Rev. 2020;84:101964.","journal-title":"Cancer Treat Rev"},{"key":"2368_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00384-019-03455-3","volume":"35","author":"C Yang","year":"2020","unstructured":"Yang C, Jiang ZK, Liu LH, Zeng MS. Pre-treatment ADC image-based random forest classifier for identifying resistant rectal adenocarcinoma to neoadjuvant chemoradiotherapy. Int J Colorectal Dis. 2020;35:101\u20137.","journal-title":"Int J Colorectal Dis"},{"key":"2368_CR34","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2967\/jnumed.118.222893","volume":"61","author":"ME Mayerhoefer","year":"2020","unstructured":"Mayerhoefer ME, Materka A, Langs G, H\u00e4ggstr\u00f6m I, Szczypi\u0144ski P, Gibbs P, et al. Introduction to radiomics. J Nucl Med. 2020;61:488\u201395.","journal-title":"J Nucl Med"},{"key":"2368_CR35","doi-asserted-by":"publisher","first-page":"e221529","DOI":"10.1148\/radiol.221529","volume":"307","author":"VS Jayaprakasam","year":"2023","unstructured":"Jayaprakasam VS, Alvarez J, Omer DM, Gollub MJ, Smith JJ, Petkovska I. Watch-and-wait approach to rectal cancer: the role of imaging. Radiology. 2023;307:e221529.","journal-title":"Radiology"},{"key":"2368_CR36","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1148\/rg.2019180075","volume":"39","author":"KR Kalisz","year":"2019","unstructured":"Kalisz KR, Enzerra MD, Paspulati RM. MRI evaluation of the response of rectal cancer to neoadjuvant chemoradiation therapy. Radiographics. 2019;39:538\u201356.","journal-title":"Radiographics"},{"key":"2368_CR37","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1007\/s00330-019-06565-2","volume":"30","author":"JK Jang","year":"2020","unstructured":"Jang JK, Choi SH, Park SH, Kim KW, Kim HJ, Lee JS, et al. MR tumor regression grade for pathological complete response in rectal cancer post neoadjuvant chemoradiotherapy: a systematic review and meta-analysis for accuracy. Eur Radiol. 2020;30:2312\u201323.","journal-title":"Eur Radiol"},{"key":"2368_CR38","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3348\/kjr.2020.0483","volume":"21","author":"SH Park","year":"2020","unstructured":"Park SH, Cho SH, Choi SH, Jang JK, Kim MJ, Kim SH, et al. MRI assessment of complete response to preoperative chemoradiation therapy for rectal cancer: 2020 guide for practice from the Korean society of abdominal radiology. Korean J Radiol. 2020;21:812\u201328.","journal-title":"Korean J Radiol"},{"key":"2368_CR39","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00330-018-5683-9","volume":"29","author":"Y Cui","year":"2019","unstructured":"Cui Y, Yang X, Shi Z, Yang Z, Du X, Zhao Z, et al. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol. 2019;29:1211\u201320.","journal-title":"Eur Radiol"},{"key":"2368_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.radonc.2021.06.019","volume":"161","author":"BS Jang","year":"2021","unstructured":"Jang BS, Lim YJ, Song C, Jeon SH, Lee KW, Kang SB, et al. Image-based deep learning model for predicting pathological response in rectal cancer using post-chemoradiotherapy magnetic resonance imaging. Radiother Oncol. 2021;161:183\u201390.","journal-title":"Radiother Oncol"},{"key":"2368_CR41","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s42256-019-0048-x","volume":"1","author":"C Rudin","year":"2019","unstructured":"Rudin C. Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead. Nat Mach Intell. 2019;1:206\u201315.","journal-title":"Nat Mach Intell"},{"key":"2368_CR42","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nrgastro.2014.41","volume":"11","author":"RG Beets-Tan","year":"2014","unstructured":"Beets-Tan RG, Beets GL. MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer. Nat Rev Gastroenterol Hepatol. 2014;11:480\u20138.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2368_CR43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejca.2021.01.028","volume":"147","author":"M Jiang","year":"2021","unstructured":"Jiang M, Li CL, Luo XM, Chuan ZR, Lv WZ, Li X, et al. Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer. Eur J Cancer. 2021;147:95\u2013105.","journal-title":"Eur J Cancer"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02368-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-023-02368-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02368-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T19:26:28Z","timestamp":1703445988000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-023-02368-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2368"],"URL":"https:\/\/doi.org\/10.1186\/s13014-023-02368-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2910052\/v1","asserted-by":"object"}]},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"assertion":[{"value":"9 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate."}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"179"}}